Emmanuel Bey

Rethinking mechanisms, diagnosis and management of endometriosis

Synthesis of Extended π‐Systems through C–H Activation

A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry

3d Transition Metals for C–H Activation

Contribution of Organofluorine Compounds to Pharmaceuticals

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Optimization of Hydroxybenzothiazoles as Novel Potent and Selective Inhibitors of 17β-HSD1

Room Temperature Copper(II)-Catalyzed Oxidative Cyclization of Enamides to 2,5-Disubstituted Oxazoles via Vinylic C–H Functionalization

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Programmed Synthesis of Tetraarylthiophenes through Sequential C−H Arylation

Precise Modulation of CO₂ Sorption in Ti₈Ce₂–Oxo Clusters: Elucidating Lewis Acidity of the Ce Metal Sites and Structural Flexibility

Oxidative C–H/C–H Coupling Reactions between Two (Hetero)arenes

Metal-Catalyzed Decarboxylative C–H Functionalization

Current and emerging treatment options for endometriosis

Carboxylic Acids as Traceless Directing Groups for the Rhodium(III)‐Catalyzed Decarboxylative CH Arylation of Thiophenes

Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?

Applications of Fluorine in Medicinal Chemistry

Mechanochemistry as an emerging tool for molecular synthesis: what can it offer?

Novel estrone mimetics with high 17β-HSD1 inhibitory activity

Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)

Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells

Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases

Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)

New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity